Absci (ABSI) Non Operating Income (2020 - 2026)
Absci (ABSI) reported Non Operating Income of $1.3 million for Q1 2026, down 8.27% on a YoY basis from $1.4 million in Q1 2025, and down 3.95% sequentially from $1.3 million in Q4 2025.
Absci (ABSI) Non Operating Income (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Non Operating Income data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 8.27% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (down 10.66% YoY), and the FY2025 full-year result was $5.2 million, down 11.09% from the prior year.
- Non Operating Income slipped to $1.3 million in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $2.0 million in Q2 2024 to a low of -$70000.0 in Q1 2022.
- A 5-year average of $1.1 million and a median of $1.3 million in 2026 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income jumped 9450.0% in 2022 and slumped 51.55% in 2025, its largest moves.
- Tracing ABSI's Non Operating Income over 5 years: stood at $1.1 million in 2022, then rose by 10.7% to $1.2 million in 2023, then tumbled by 34.62% to $812000.0 in 2024, then jumped by 62.19% to $1.3 million in 2025, then retreated by 3.95% to $1.3 million in 2026.
- Business Quant data shows ABSI's Non Operating Income at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Absci | 1.16 Bn | 1.03 Bn | - | 1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 955,000.00 |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 812,000.00 |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.14 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Sep 30, 2022 | 396,000.00 |
| Jun 30, 2022 | -63,000.00 |
| Mar 31, 2022 | -70,000.00 |
| Dec 31, 2021 | -12,000.00 |
| Sep 30, 2021 | -4.20 Mn |
| Jun 30, 2021 | -30.12 Mn |